⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AKTX News
Akari Therapeutics plc ADR (0.01 USD)
Form 8-K
sec.gov
AKTX
Akari Therapeutics Announces ADS Ratio Change
globenewswire.com
AKTX
Akari Therapeutics Announces ADS Ratio Change
globenewswire.com
AKTX
Akari Therapeutics Releases CEO Corner Highlighting Strategic Progress and Path to Clinical Development Under CEO Abizer Gaslightwala
globenewswire.com
AKTX
Form 8-K
sec.gov
AKTX
Akari Therapeutics Appoints Leading Cancer Biology and RNA Expert, Prafulla Gokhale, Ph.D., to Scientific Advisory Board
globenewswire.com
AKTX
Akari Therapeutics Appoints Globally Recognized Expert in RNA Biology and Cancer Research, Olga Anczukow, Ph.D., to its Scientific Advisory Board
globenewswire.com
AKTX
Akari Therapeutics to Present at the 2026 Biocom Global Partnering & Investor Conference
globenewswire.com
AKTX
Akari Therapeutics Participates in Virtual Investor “What This Means” Interview Discussing the Company’s Expanded ADC Pipeline
globenewswire.com
AKTX
JTC Team Companies to Present in Webull Corporate Connect Webinar Series Happening February 10-11, 2026
accessnewswire.com
AKTX
DCOY
GRI
MBRX
AIM
BULL